Phase 2 Alzheimer's Disease Trial, By Invitation NCT06723015 Sponsor: Mayo Clinic Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 2 Alzheimer's Disease Trial, By Invitation

NCT06723015
By Invitation Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 90 years old.
  • Both men and women are eligible.
  • People who have been diagnosed with mild memory or thinking problems, or mild Alzheimer's disease.
  • People who have tested positive for amyloid (a protein linked to Alzheimer's disease) through a spinal fluid test or a brain scan.
  • People who meet the other eligibility requirements for a type of Alzheimer's treatment called anti-amyloid immunotherapy (confirm with trial site).
  • The person joining the trial, or their legal representative, is willing and able to give consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to lie still without moving for at least 10 minutes.
  • Women who are pregnant or who are unable to stop breastfeeding for 24 hours.
  • People who have a fear of enclosed spaces (claustrophobia) that would prevent them from tolerating the scans, as no sedation is available for this purpose.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 August 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 2
Sponsor
Registry
ClinicalTrials.gov
Start date
4 November 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in tau PET Standardized Uptake Value (SUVR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov